Compound 225
Identifiers
- Canonical SMILES:
CCN(CC)C(=O)c1nn(c(C)c1Br)-c1ccccc1C(=O)N1Cc2ccccc2C[C@H]1CO
- IUPAC name:
4-bromo-N,N-diethyl-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide
- InChi:
InChI=1S/C26H29BrN4O3/c1-4-29(5-2)26(34)24-23(27)17(3)31(28-24)22-13-9-8-12-21(22)25(33)30-15-19-11-7-6-10-18(19)14-20(30)16-32/h6-13,20,32H,4-5,14-16H2,1-3H3/t20-/m0/s1
- InChiKey:
MBRSVHOHDRQYGO-FQEVSTJZSA-N
External links
44570086 |
CHEMBL520607 |
24718492 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.44 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 524.14 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 3.86 | |||
TPSA | 78.67 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5481 | Apixaban | DB06605 | |
0.4954 | Alosetron | DB00969 | |
0.4903 | Meclinertant | DB06455 | |
0.4646 | Rimonabant | DB06155 | |
0.4618 | Surinabant | DB13070 | |
0.4440 | 1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole | DB04030 | |
0.4361 | SD146 | DB02729 | |
0.4358 | Danusertib | DB11778 | |
0.4348 | PF-06291874 | DB15065 | |
0.4318 | 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE | DB08527 | |
0.4280 | JHU-75528 C-11 | DB14902 | |
0.4267 | Implitapide | DB04852 | |
0.4245 | Flumazenil | DB01205 | |
0.4239 | Eluxadoline | DB09272 | |
0.4223 | Granisetron | DB00889 |